Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma

3 months ago 12
For patients with clear-cell renal compartment carcinoma, pembrolizumab-belzutifan yields importantly higher disease-free survival, according to a survey published successful the July 2 contented of the New England Journal of Medicine.
Read Entire Article